PREFERMS study: fingolimod switch effect on patient retention, key clinical outcomes and patient satisfaction

被引：0
|
作者：
Hunter, S. F. [1 ]
Cascione, M. [2 ]
Thomas, F. P. [3 ]
Cree, B. A. C. [4 ]
Meng, X. [5 ]
Schofield, L. [5 ]
Tenenbaum, N. [5 ]
机构：
[1] Adv Neurosci Inst, Franklin, TN USA
[2] Tampa Neurol Associates, Tampa, FL USA
[3] St Louis Univ, St Louis, MO 63103 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Novartis Pharmaceut, E Hanover, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1496
引用
收藏
页码：782 / 782
页数：1
相关论文
共 50 条
  • [1] PREFERMS study: post hoc analyses of patient retention, key clinical outcomes and patient satisfaction in an African-American patient subgroup
    Cascione, M.
    Wendt, J.
    Cree, B. A. C.
    Meng, X.
    Schofield, L.
    Tenenbaum, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 608 - 608
  • [2] PREFERMS study: post hoc analyses of patient retention, key clinical outcomes and patient satisfaction in an African-American patient subgroup
    Cascione, Mark
    Wendt, Jeanette
    Cree, Bruce
    Meng, Xiangyi
    Schofield, Lesley
    Tenenbaum, Nadia
    [J]. NEUROLOGY, 2017, 88
  • [3] PREFERMS Study: fingolimod switch effect on volumetric MRI and cognitive outcomes
    Hunter, S. F.
    Thomas, F. P.
    Cree, B. A.
    Meng, X.
    Schofield, L.
    Boulos, F.
    Tenenbaum, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 614 - 614
  • [4] Switching to fingolimod in PREFERMS: Effect of treatment history and naivety on clinical, MRI and treatment satisfaction outcomes
    Hunter, Samuel F.
    Thomas, Florian P.
    Cascione, Mark
    Williams, Ian M.
    Meng, Xiangyi
    Schofield, Lesley
    Weiss, Jamie L.
    Tenenbaum, Nadia
    Cree, Bruce A. C.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [5] Comparison of treatment retention and efficacy outcomes with fingolimod, interferons and glatiramer acetate in PREFERMS
    Thomas, Florian
    Arnold, Douglas
    Cascione, Mark
    Fox, Edward
    Vieira, Maria Cecilia
    Ko, John
    Meng, Xiangyi
    Schofield, Lesley
    Boulos, Fernanda
    Tenenbaum, Nadia
    Cree, Bruce A. C.
    [J]. NEUROLOGY, 2017, 88
  • [6] Effect of previous therapies on treatment retention and satisfaction in patients randomized to fingolimod or injectable disease-modifying therapies in PREFERMS
    Thomas, Florian P.
    Hunter, Samuel F.
    Meng, Xiangyi
    Schofield, Lesley
    Kolodny, Scott
    Tenenbaum, Nadia
    Cree, Bruce A. C.
    [J]. NEUROLOGY, 2018, 90
  • [7] Key Results fro PREFERMS: Real-World Patient Retention and Outcomes on Fingolimod versus Platform Injectable Disease-Modifying Therapies in Early Relapsing-Remitting Multiple Sclerosis
    Cree, Bruce
    Wynn, Daniel
    Cascione, Mark
    Meng, Xiangyi
    Schofield, Lesley
    Tenenbaum, Nadia
    [J]. NEUROLOGY, 2016, 86
  • [8] PREFERMS study: post hoc analyses of treatment satisfaction in patient subgroups, using the Medication Satisfaction Questionnaire
    Thomas, F. P.
    Crayton, H.
    Steingo, B.
    Meng, X.
    Johnson, K.
    Schofield, L.
    Tenenbaum, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 779 - 780
  • [9] Treatment satisfaction and clinical improvement after switch to fingolimod
    Fox, E.
    Edwards, K.
    Burch, J. G.
    Kim, E.
    Pestreich, L.
    McCague, K.
    Barbato, L.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 : S126 - S126
  • [10] Satisfaction and Efficacy Outcomes When Switching from Injectable Disease-Modifying Therapies to Fingolimod in PREFERMS: Effect of Previous Treatment
    Hunter, Samuel F.
    Cree, Bruce A. C.
    Meng, Xiangyi
    Schofield, Lesley
    Kolodny, Scott
    Tenenbaum, Nadia
    Thomas, Florian P. P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 19 - 19
12345